Fatty liver disease: the silent condition on your blood test
Last updated September 3, 2026.
Fatty liver disease means excess fat stored in the liver, and it usually causes no symptoms while quietly being the most common liver condition in the world. The current name is MASLD (metabolic dysfunction-associated steatotic liver disease), previously NAFLD. It travels with weight gain, type 2 diabetes, and cholesterol problems, and it matters because a minority progress to inflammation, scarring, and eventually cirrhosis, while the majority can reverse the fat with lifestyle change.
How is it found, and what do the stages mean?
Most people discover it by accident: mildly raised liver enzymes (ALT) on a routine blood test, or a mention of a fatty liver on an ultrasound done for something else. There are usually no symptoms; fatigue and a vague right-upper-abdomen ache are occasionally reported but nonspecific. The staging is what drives decisions. Simple steatosis (fat only) is the common, lower-risk stage. Steatohepatitis (MASH, fat plus inflammation) is the progressive form. Fibrosis is scarring, graded from mild to cirrhosis, where the damage is permanent and complications like liver failure and cancer enter. Doctors estimate your stage with a fibrosis score from routine bloods (FIB-4), an ultrasound-based stiffness scan (FibroScan), or occasionally biopsy.
Who progresses?
The honest answer is that most people with fatty liver never develop serious liver disease, but the minority who do are predictable: type 2 diabetes, obesity (especially central), high blood pressure, high triglycerides, and older age stack the risk. That is why a fibrosis risk score is calculated at diagnosis; a low score is managed in primary care with lifestyle and periodic rechecks, while a high score earns a hepatology referral. Alcohol intake is assessed honestly at the same time, because fat plus alcohol multiplies the damage.
What actually helps?
- Lose 7-10% of body weight if overweight: the single most effective treatment. Trials show 7% loss reduces liver inflammation, and 10% can reverse early scarring. Slow loss (half to one kilogram a week) beats crash dieting.
- Exercise, with or without weight loss: 150 minutes weekly of moderate aerobic activity plus resistance training reduces liver fat measurably even when the scale does not move.
- Mediterranean-style eating: vegetables, fish, olive oil, nuts, whole grains, minimal processed food. The specific villain to cut is sugary drinks and fructose-heavy processed food, which drive liver fat directly.
- Manage the metabolic partners: tight diabetes, blood pressure, and cholesterol control is liver treatment too. Some diabetes drugs (pioglitazone, GLP-1 agonists like semaglutide) have direct liver benefits.
- Alcohol honesty: even moderate drinking adds injury to a fatty liver; the lower the better, and advanced fibrosis means none.
When is it an emergency?
Fatty liver itself is never an emergency; the emergencies belong to advanced cirrhosis that was missed: vomiting blood, black stools, confusion and sleepiness (encephalopathy), a rapidly swelling abdomen, or yellowing of the eyes and skin all mean urgent assessment. For everyone earlier in the process, the danger is the opposite problem: complacency. A fatty liver flagged on a scan deserves a fibrosis risk score and a real plan, not a shrug and a yearly repeat of the same blood test. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Can fatty liver disease be reversed?
Yes, at the early stages, and that is the good news worth acting on. Losing 7-10% of body weight reduces liver fat and inflammation, and 10% or more can regress even fibrosis in trial data. Exercise reduces liver fat independently of weight loss. Once cirrhosis (advanced scarring) is established, it is generally permanent, though progression can still be slowed dramatically. The window where your choices fully control the outcome is now, which is why staging matters.
Does fatty liver disease have symptoms?
Almost never, until very advanced. Fatigue and a vague discomfort under the right ribs are reported by some, but most people feel nothing through the entire steatosis and even fibrosis stages. Symptoms arrive with cirrhosis: swelling abdomen, yellowing eyes, easy bruising, confusion. The condition is found on blood tests and scans, not felt. This is why the abnormal ALT or the ultrasound comment deserves follow-through: the silence is the disease working, not the disease absent.
What is the difference between fatty liver and alcoholic liver disease?
The naming has shifted to reflect the overlap. MASLD (formerly NAFLD) is fat accumulation driven by metabolic factors: weight, diabetes, cholesterol. Alcohol-associated liver disease (ALD) is driven by drinking. Many people have both, and the new umbrella term steatotic liver disease acknowledges that fat plus alcohol multiplies damage rather than adding it. The blood tests and scans look similar; the history separates them, which is why honesty about alcohol intake changes the accuracy of the staging.
Do I need a liver biopsy?
Usually not. Non-invasive tools handle most staging: the FIB-4 score (computed from age, platelets, and standard liver enzymes), FibroScan (an ultrasound-based stiffness measurement), and sometimes blood-based fibrosis panels. Biopsy remains the reference standard and is used when non-invasive results disagree, the diagnosis is uncertain, or trial-level precision is needed. For the typical person with a fatty liver on ultrasound and a low fibrosis score, no biopsy, no scope, just a plan and a recheck.
Are there medications for fatty liver?
Until recently, none specifically approved, and that has just changed: resmetirom was approved for MASH with moderate-to-advanced fibrosis. For most patients the real pharmacology is indirect: GLP-1 agonists (semaglutide) and pioglitazone help selected patients with diabetes, statins are safe and recommended for cholesterol in fatty liver (an old myth says otherwise), and vitamin E has a narrow role in biopsy-proven MASH without diabetes. The foundation remains weight, movement, and metabolic control.
How often should fatty liver be monitored?
For low-risk staging: annual blood tests and a recalculated fibrosis score, with lifestyle as the active treatment. FibroScan every 1-2 years is common when available. Higher scores or confirmed significant fibrosis move you to specialist care with closer surveillance, and cirrhosis brings its own schedule: ultrasound and AFP blood test every 6 months for liver cancer screening, plus endoscopy to check for varices. The monitoring interval follows the stage, which is why getting staged once, properly, is the task after any incidental finding.